Transferrin is a 76-kDa glycoprotein in blood plasma that binds and transports ferric iron (Fe³⁺) with extremely high affinity (Kd ~10⁻²² M) between sites of absorption, storage, and utilization while keeping iron sequestered from pathogens. It serves dual functions: nutrient delivery to cells requiring iron (erythropoiesis, mitochondrial function) and antimicrobial defense through nutritional immunity. Transferrin saturation (normally 20-40%) reflects the balance between iron availability for host metabolism and iron withholding from invading microorganisms.
Think of transferrin as an armoured courier in a medieval city under siege. The courier carries two iron strongboxes (Fe³⁺ binding sites) and delivers them only to cells with the correct keys (transferrin receptors). Normally, the courier carries only one of the two boxes full — leaving one empty to quickly grab any "loose iron" dropped on the streets (free Fe³⁺), preventing enemy soldiers (bacteria) from scavenging it. When the city is under attack (infection/inflammation), the central command (liver) releases hepcidin, which locks the iron vaults (blocks ferroportin on macrophages and enterocytes), trapping iron inside storage cells. Now the courier runs mostly empty (low transferrin saturation) — starving the invaders while the city's own defenders (immune cells) use stored iron internally. Enemy soldiers deploy special thieves (siderophores) to try stealing iron from the courier, but the strongboxes are near-impenetrable. This is nutritional immunity: withhold the resource, win the war.
Transferrin-mediated iron delivery and sequestration operates through the following cascade:
Normal iron transport:
- Transferrin binds two Fe³⁺ ions at specific binding sites (N-lobe and C-lobe) with Kd ~10⁻²² M
- Diferric transferrin (holo-transferrin) circulates in plasma at 2-3 g/L
- Cells requiring iron upregulate transferrin receptor 1 (TfR1) on their surface
- Holo-transferrin binds TfR1 (Kd ~10⁻⁹ M) → receptor-mediated endocytosis via clathrin-coated pits
- Inside acidic endosomes (pH ~5.5), Fe³⁺ dissociates from transferrin
- DMT1 (divalent metal transporter 1) transports Fe²⁺ into cytoplasm after reduction
- Apo-transferrin (iron-free) remains bound to TfR1, returns to cell surface at neutral pH, then dissociates to reload in plasma
Inflammatory iron sequestration:
- Infection/tissue damage → PAMPs/DAMPs activate immune cells
- Macrophages produce IL-6 → hepatocytes upregulate hepcidin transcription
- Hepcidin binds ferroportin (sole cellular iron exporter) on macrophages, enterocytes, hepatocytes
- Ferroportin internalization and degradation → iron trapped intracellularly
- Reduced iron release → decreased transferrin saturation (can drop to <10%)
- Low-iron plasma environment → bacterial iron starvation
Bacterial countermeasures:
- Siderophores (bacterial iron chelators) compete with transferrin (some with Kd ~10⁻²³ M)
- Species-specific siderophore receptors on bacteria (e.g., FepA for enterobactin in E. coli)
- Some pathogens (Neisseria) express transferrin-binding proteins (TbpA/TbpB) to directly steal iron
graph TD
A[Dietary Iron/Recycled RBC Iron] -->|Ferroportin| B[Plasma]
B --> C["Diferric Transferrin Fe³⁺-Tf-Fe³⁺"]
C -->|TfR1 binding| D[Target Cell Endocytosis]
D -->|pH 5.5| E["Fe³⁺ Release"]
E -->|DMT1| F[Cytoplasmic Iron Pool]
F --> G[Ferritin Storage]
F --> H[Mitochondrial Use]
F --> I[Heme Synthesis]
J[Infection/Inflammation] -->|PAMPs/DAMPs| K[IL-6 Release]
K --> L[Hepatic Hepcidin Production]
L -->|Binds & Degrades| M[Ferroportin Blocked]
M --> N[Iron Trapped in Macrophages/Enterocytes]
N --> O[Low Transferrin Saturation]
O --> P[Bacterial Iron Starvation]
Q[Bacteria] -->|Siderophores| C
Q -->|TbpA/B receptors| C
Transferrin saturation is a critical diagnostic and therapeutic decision point in cPNI because it distinguishes true iron deficiency from inflammatory iron sequestration (anemia of chronic disease):
True iron deficiency:
- Low transferrin saturation (<20%)
- Low ferritin (<30 μg/L women, <40 μg/L men)
- High total iron-binding capacity (TIBC >400 μg/dL)
- Intervention: iron supplementation (with caution — see below)
Anemia of chronic disease (functional iron deficiency):
- Low transferrin saturation (<20%)
- Normal or high ferritin (>100 μg/L) — iron sequestered, not deficient
- Low TIBC (<250 μg/dL)
- Intervention: do NOT supplement iron — address underlying inflammation first
Clinical applications:
- Chronic low-grade inflammation: sustained hepcidin elevation (from IL-6, obesity, insulin resistance) reduces transferrin saturation chronically, creating pseudo-iron deficiency while promoting oxidative stress from trapped intracellular iron
- Oral barrier dysfunction: periodontitis and tooth loss release bacteria (Porphyromonas gingivalis) that trigger systemic hepcidin → iron sequestration → contributes to fatigue and cognitive decline
- Diabetes and cardiovascular disease: iron dysregulation correlates with CVD risk — excess stored iron (high ferritin, high transferrin saturation >45%) promotes ROS generation and atherosclerosis
- Pathogen defense: inappropriate iron supplementation during active infection can fuel bacterial growth — many pathogens (Salmonella, E. coli, Staphylococcus) require iron for virulence factor expression
Evolutionary mismatch: Modern high-heme iron diets (red meat) combined with low infection burden disrupt evolved nutritional immunity calibration — historically, dietary iron was scarce and infection burden high, favouring tight iron sequestration. Today's iron excess + chronic inflammation = oxidative damage without antimicrobial benefit.
Intervention strategy:
- Measure both transferrin saturation AND ferritin before iron supplementation
- If ferritin >100 μg/L with low saturation → investigate inflammatory drivers (gut barrier, oral health, metabolic dysfunction, chronic infection)
- Address chronic low-grade inflammation via five metamodels: optimize sleep, movement, gut barrier, psychological stress, nutritional quality
- Consider lactoferrin (100-300 mg/day) instead of ferrous sulfate — delivers iron while maintaining antimicrobial function
- Monitor CRP, IL-6, hepcidin (if available) alongside iron panels
- Transferrin normally circulates at 2-3 g/L with 20-40% iron saturation in healthy individuals
- Each transferrin molecule binds exactly two Fe³⁺ ions (one per lobe) with affinity Kd ~10⁻²² M
- Iron-binding capacity: total iron-binding capacity (TIBC) = serum transferrin × 1.41 (normal 250-400 μg/dL)
- Transferrin saturation = (serum iron / TIBC) × 100%; <20% indicates functional or absolute iron deficiency, >45% indicates iron overload risk
- Hepcidin half-life ~3 hours; IL-6 elevation increases hepcidin 5-10 fold within 6 hours of inflammatory stimulus
- Transferrin synthesis decreases during acute inflammation (negative acute phase protein), reducing total iron-binding capacity
- Bacterial siderophores can achieve Kd ~10⁻²³ to 10⁻⁵² M depending on species — evolutionary arms race with transferrin
- Transferrin receptor 1 (TfR1) density on cells increases 5-10 fold during iron deficiency (IRE/IRP regulation)
- Congenital atransferrinemia (complete absence) causes severe microcytic anemia and iron overload in tissues — demonstrating transferrin's dual role
- Serum transferrin <2 g/L indicates either inflammation or protein-energy malnutrition (negative acute phase response or liver dysfunction)
- iron — primary cargo molecule; transferrin maintains Fe³⁺ in soluble, redox-inactive, bioavailable form
- ferritin — intracellular iron storage protein; mirrors transferrin function (storage vs transport), both regulated by hepcidin axis
- hepcidin — master regulator of iron homeostasis; blocks ferroportin → reduces transferrin saturation during inflammation
- IL-6 — primary hepcidin inducer; links inflammation to iron sequestration via IL-6 → STAT3 → hepcidin promoter
- ferroportin — sole cellular iron exporter; hepcidin-mediated degradation creates iron sequestration and low transferrin saturation
- nutritional immunity — transferrin is keystone molecule in iron-withholding strategy against pathogens
- inflammation — acute phase response simultaneously increases hepcidin and decreases transferrin synthesis
- anemia of chronic disease — functional iron deficiency from hepcidin-mediated sequestration despite adequate ferritin stores
- siderophores — bacterial iron chelators that compete with transferrin; species-specific evolutionary countermeasure
- lactoferrin — mucosal iron-binding protein with similar sequestration function but broader antimicrobial activity
- chronic low-grade inflammation — sustained IL-6 elevation → persistent hepcidin → chronically low transferrin saturation → fatigue, cognitive dysfunction
- insulin resistance — correlates with hepcidin dysregulation and altered iron metabolism independent of inflammation
- oral barrier — periodontitis and dental infections drive systemic hepcidin via IL-6, reducing transferrin saturation
- diabetes — iron dysregulation (both deficiency and excess) linked to β-cell dysfunction and peripheral insulin resistance
- tooth loss — independent mortality predictor via chronic inflammation → iron sequestration → anemia → reduced tissue oxygenation
- macrophages — primary iron storage site during inflammation; recycling of senescent RBCs via ferroportin blockade
- oxidative stress — free iron (Fe²⁺) catalyzes Fenton reaction (Fe²⁺ + H₂O₂ → Fe³⁺ + OH• + OH⁻); transferrin binding prevents this
- pathogen — target of nutritional immunity; many pathogens require iron for growth, toxin production, biofilm formation
- haemoglobin — end-use destination for iron delivered via transferrin to erythroblasts in bone marrow
- cardiovascular disease — iron overload (high transferrin saturation >45%) promotes atherosclerosis via LDL oxidation and endothelial dysfunction
- immune system — uses transferrin as antimicrobial effector molecule; IFN-γ upregulates transferrin production in monocytes
- C-reactive protein — co-marker with transferrin saturation to distinguish infection/inflammation from true iron deficiency
- VEGF — iron deficiency (low transferrin saturation) impairs HIF-1α stabilization → reduced VEGF → impaired wound healing
- EPO — erythropoietin production requires adequate iron delivery via transferrin; chronic sequestration causes EPO resistance
- Module 2: Evolutionary Medicine — iron dysregulation in mismatch diseases, nutritional immunity as evolutionary defense
- Module 6: Organs I — oral barrier dysfunction driving systemic iron sequestration, tooth loss and mortality mechanisms